The aim of this conference is to gather the RNA Binding Proteins (RBP) community and focus on the potentiality of these proteins as druggable targets. RNA-binding proteins are fundamental regulators of gene expression programs. RBPs organize in ribonucleotide complexes (RNPs) together with RNAs and additional proteins regulating all aspects of RNA life. Many reports suggest that alterations in RBPs homeostasis can lead to the insurgence of many pathologies. However, so far no approved drugs are specifically targeting RBPs but now technologies are mature enough to provide substantial contribution to the development of novel therapeutics.
FASEB Conferences Diversity Statement:
FASEB is committed to sustaining diversity, equity, accessibility, and inclusion in the biological and biomedical sciences. FASEB’s goal is to create and support a conference environment that is welcoming and safe for all. FASEB believes inclusion of diverse participants, including attendees and speakers, is critical to the scientific and educational integrity of conferences. Organizers are expected to design programs that reflect this commitment. As part of FASEB’s ongoing assessment towards reaching its diversity goals, conference participants are asked to share diversity information. Any data collected from individuals is treated confidentially and used in aggregate format for internal and external review. For more information, please visit https://www.faseb.org/diversity-equity-and-inclusion